Abstract:
The aim of the study is to choose the optimal tactics of surgical treatment in patients with colorectal cancer (CRC) with synchronous
intra-abdominal metastases.
Materials and methods: The study included 74 patients with CRC with synchronous intra-abdominal metastases (peritoneal carcinomatosis
and/or liver metastases), which were divided into 3 groups: I group (25 patients)-Intestinal stoma + neoadjuvant chemotherapy + Cytoreductive Surgery (CRS) + Adjuvant Chemotherapy (ACT); II group (18 patients)-Colon/rectal resection + ACT + CRS + ACT; III group (31 patients)-CRS + ACT.
Results: The best oncological results were obtained in III group (median overall survival 46 months vs 27m. in I group and 31m. in II group).
In contrast, a higher incidence of postoperative complications was observed also in this group (29%). There is no significant difference in overall
survival (p>0.05 according to Log-Rank test) and the rate of postoperative complications between all groups of patients. The mean length of
hospital stay was shorter in III group-9.8 days (p<0.01).
Conclusions: All three options could be selected for the treatment of synchronous metastatic CRC. Therefore, the main goal remains the
achievement of complete cytoreduction. So, it is necessary to focus on its possibility when choosing the sequence of stages of treatment in such
patients. However, if it is possible to achieve complete cytoreduction and in the setting of the oncological center it is recommended cytoreductive
surgery as the first step followed by adjuvant chemotherapy as the best treatment tactics for patients with synchronous metastatic CRC.
